hero section gradient
15 handpicked stocks

Future of Housing Portfolio

Meet the innovators transforming how we build homes. These carefully selected companies are tackling the housing crisis with groundbreaking technologies—from 3D printing to modular construction—making housing more affordable, sustainable, and accessible for everyone.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Summary and key takeaways for investors based on the provided market capitalisation breakdown for the Future of Housing Portfolio.

Key Takeaways for Investors:
  • Large-cap dominance implies generally lower volatility and closer tracking of broad-market moves, reducing tail-risk compared with small-cap baskets.
  • Suitable as a core, strategic holding for diversification, not a speculative, high-growth allocation.
  • Expect steadier, long-term appreciation rather than rapid, short-term gains; growth is likely moderate.
Total Market Cap
  • SKY: $4.36B

  • DDD: $433.49M

  • CVCO: $4.57B

  • Other

About This Group of Stocks

1

Our Expert Thinking

This portfolio focuses on the technological revolution in construction that's poised to solve the housing affordability crisis. By identifying companies pioneering faster, cheaper, and more sustainable building methods, we're capturing a major industrial transformation that traditional markets haven't fully recognized.

2

What You Need to Know

These companies span the housing innovation spectrum—from pure-play tech firms developing 3D printing solutions to established homebuilders adopting factory-built components. Current economic conditions, including high labor costs and material inflation, create perfect conditions for these alternative building approaches to thrive.

3

Why These Stocks

We've selected industry leaders who are either creating the technology for the future of housing or implementing it at scale. These companies are uniquely positioned to benefit from growing demand for affordable homes while addressing sustainability concerns that traditional construction can't easily solve.

Why You'll Want to Watch These Stocks

🏠

The Affordable Housing Revolution

These companies are solving one of society's biggest challenges: the housing crisis. Their innovations could make homeownership accessible to millions priced out of traditional markets.

🚀

Building Homes Twice as Fast

Imagine homes built in days instead of months. These technologies are dramatically shortening construction timelines, creating a competitive advantage that traditional builders can't match.

🌱

The Green Building Boom

Sustainable construction is no longer just a trend—it's becoming a requirement. These companies are pioneering eco-friendly building methods that reduce waste and energy consumption.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions